# Recourse Biologics, Inc. — Form D

Recourse Biologics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-08. The offering totals $4.3M, of which $2.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-10-08
- Form: D
- Accession: 0002038107-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.3M
- Amount sold: $2.8M
- Remaining: $1.5M
- Investors: 14
- Date of first sale: 2024-09-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-526186

## Issuer

- Name: Recourse Biologics, Inc.
- CIK: 0002038107
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 3737 BUFFALO SPEEDWAY, HOUSTON, TX, 77098
- Phone: (713) 304-3057

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Alexander Krupnick | Director | Houston, TX |
| Daniel Watkins | Director | Houston, TX |
| John K Westwick | Director | Houston, TX |
| Daniel Watkins | Executive Officer | Houston, TX |
| John K Westwick | Executive Officer | Houston, TX |

## More

- [CIK 2038107 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2038107&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002038107-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.